In the setting of decreased PPARγ expression in obesity, the typical pattern observed includes limiting further AT expansion and dysregulating adipokine production and release patterns, including low levels of adiponectin and high levels of leptin [96]. Here, ADIPOQ is linked to obesity disorder.